Filing Details

Accession Number:
0001209191-11-029527
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-05-18 19:28:21
Reporting Period:
2011-05-16
Filing Date:
2011-05-18
Accepted Time:
2011-05-18 19:28:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1316175 Anthera Pharmaceuticals Inc ANTH Pharmaceutical Preparations (2834) 201852016
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1120362 F Paul Truex C/O Anthera Pharmaceuticals, Inc.
25801 Industrial Boulevard, Suite B
Hayward CA 94545
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2011-05-03 30,000 $0.00 91,122 No 5 G Direct
Common Stock Acquisiton 2011-05-03 30,000 $0.00 716,003 No 5 G Indirect By trust
Common Stock Disposition 2011-05-09 9,000 $0.00 707,003 No 5 G Indirect By trust
Common Stock Disposition 2011-05-16 15,000 $7.16 692,003 No 4 S Indirect By trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 5 G Direct
No 5 G Indirect By trust
No 5 G Indirect By trust
No 4 S Indirect By trust
Footnotes
  1. The Reporting Person transferred 30,000 shares to The 2005 Truex Family Trust u/d/t April 20, 2005 on May 3, 2011.
  2. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 1, 2011.
  3. The price reported in Column 4 is a weighted average price. These Shares were sold in multiple transactions at prices ranging from $7.10 to $7.31, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares sold at each separate price within the range set forth in this footnote.